Unknown OBSERVATIONAL NCT03217552

The Performance of the Mologic Biomarker Panel in Infection

An Observational Study to Evaluate the Diagnostic and Predictive Accuracy of the Mologic Biomarker Panel in Patientsrnwith Severe Infection

Sponsor: Innovate UK

Conditions Infection Sepsis

Interventions Mologic Biomarker Panel

Updated 7 times since 2017 Last updated: Mar 27, 2018 Started: Nov 26, 2017 Primary completion: Apr 30, 2019 Completion: Jul 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Infection and Sepsis, this trial is ongoing. The trial is conducted by Innovate UK and has accumulated 7 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Apr 2020 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2018 — Apr 2020 [monthly]

Recruiting

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting · Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Innovate UK
Mologic Ltd
University College London Hospitals

Data source: Mologic Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom